CRISPR RiPCA for Investigating eIF4E-m7GpppX Capped mRNA Interactions
Gabriela Vega-Hernández, Jesse Duque, Brandon J. C. Klein, Dalia M. Soueid, Jason C. Rech, Hui Wang, Wenhui Zhou, Amanda L. Garner
This paper introduces CRISPR RiPCA, a platform combining CRISPR and live-cell RNA-protein interaction assays to measure inhibitor activity against eIF4E-m7GpppX interactions relevant to cancer drug discovery.
ACS Chemical Biology · Aug 7, 2025Peer-reviewedCell Biology